Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and mdl 100453

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with mdl 100453 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, BM; McDonald, IA; Miller, F; Muench, D; White, HS; Whitten, JP1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and mdl 100453

ArticleYear
(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:11

    Topics: Animals; Binding, Competitive; Cerebellum; Cyclic GMP; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Kindling, Neurologic; Mice; Mice, Inbred DBA; N-Methylaspartate; Rats; Receptors, N-Methyl-D-Aspartate; Valine

1990